Company: OSRH
Filing Date: 2025-05-28
Form Type: S-1
Source: 0001213900-25-048346
Chunk: 32

Company: OSR Holdings, Inc.
Filing Date: 2025-05-28
Form: S-1
Chunk 32
---
 to time in its discretion and at different prices. Therefore, sales to White Lion by us could result in substantial dilution to the interests of other holders of shares of our common stock. In addition, if we sell a substantial number of shares of our common stock to White Lion under the Issuance Agreements, or if investors expect that we will do so, the shares held by White Lion will represent a significant portion of our public float and may result in substantial decreases to the price of our common stock. The actual sales of shares of our common stock or the mere existence of our arrangement with White Lion may also make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect such sales. 18 The market price of shares of our common stock could drop significantly if White Lion sells shares of common stock or is perceived by the market as intending to sell them. These factors could also make it more difficult for us to raise additional funds through future offerings of shares of our common stock or other securities. We may use proceeds from sales of our common stock made pursuant to the ELOC Agreement, Warrant Agreement, and Note Purchase Agreement in ways with which you may not agree or in ways which may not yield a significant return. We will have broad discretion over the use of proceeds from sales of our common stock made pursuant to the Issuance Agreements, including for any of the purposes described in the section entitled “Use of Proceeds,” and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately. Because of the number and variability of factors that will determine our use of the net proceeds, their ultimate use may vary substantially from their currently intended use. While we expect to use the net proceeds from this offering as set forth in “Use of Proceeds,” we are not obligated to do so. The failure by us to apply these funds effectively could harm our business, and the net proceeds may be used for corporate purposes that do not increase our operating results or enhance the value of our common stock. Future sales of our common stock, or the perception in the public markets that these sales may occur, could cause the market price for our common stock to decline. Sales of a substantial number of shares of our common stock in the public market could occur at any time, subject to the restrictions and limitations described below. If our stockholders sell, or the market perceives that our stockholders intend to sell, substantial amounts